← Eichor
Study identifier: NCT05895032 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Trial of an Exercise Intervention for Children With Haemophilia

Condition: Hemophilia · Child, Only · Musculoskeletal Diseases or Conditions  ·  Sponsor: East Kent Hospitals University NHS Foundation Trust

PhaseNA
Planned participants132
Who can joinMale, 6 Years to 12 Years
Healthy volunteersNo

About this study

"Being able to participate in games and activities with their friends" is one of the things that matters most to boys with haemophilia. At present, there is a lack of robust evidence to determine whether muscle strengthening exercise can improve or negatively affect outcomes for young children with haemophilia. With the help of boys with haemophilia, their parents and physiotherapists the investigators have developed an exercise programme designed to increase muscle strength. Using this intervention the investigators will undertake a single-blinded, two-arm pragmatic randomised controlled trial (RCT) of a 12-week intervention verses usual care of boys with haemophilia aged 6-12 years of age.

This description comes directly from the study's public registry record.

Talk to the study team

David Stephensen, PhD  ·  01227783166  ·  david.stephensen@nhs.net

Always discuss trial participation with your own doctor first.

Locations (1)

Haemophilia CentreCanterbury, Kent, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05895032